These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 30896658)
1. The diagnostic value of circulating tumor cells for lung cancer: A systematic review and meta-analysis. Ye Y; Li SL; Wang JJ; Liu B Medicine (Baltimore); 2019 Mar; 98(12):e14936. PubMed ID: 30896658 [TBL] [Abstract][Full Text] [Related]
2. Circulating tumor cells as a potential biomarker in diagnosis of lung cancer: a systematic review and meta-analysis. Huang H; Shi Y; Huang J; Wang X; Zhang R; Chen H Clin Respir J; 2018 Feb; 12(2):639-645. PubMed ID: 27778482 [TBL] [Abstract][Full Text] [Related]
3. Role of circulating tumor cells in diagnosis of lung cancer: a systematic review and meta-analysis. Zhao Q; Yuan Z; Wang H; Zhang H; Duan G; Zhang X J Int Med Res; 2021 Mar; 49(3):300060521994926. PubMed ID: 33682521 [TBL] [Abstract][Full Text] [Related]
4. A meta-analysis of the value of circulating tumor cells in monitoring postoperative recurrence and metastasis of colorectal cancer. Wu J; Li Z; Zou J; Li L; Cui N; Hao T; Yi K; Yang J; Wu Y PLoS One; 2022; 17(9):e0274282. PubMed ID: 36121855 [TBL] [Abstract][Full Text] [Related]
5. The value of folate receptor-positive circulating tumour cells as a diagnostic biomarker for lung cancer: a systematic review and meta-analysis. Chen F; Ni Y; Zhang J; Hao Y; Tian Z; Qiang G J Int Med Res; 2023 Sep; 51(9):3000605231199763. PubMed ID: 37751487 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic accuracy of circulating tumor cells detection in gastric cancer: systematic review and meta-analysis. Tang L; Zhao S; Liu W; Parchim NF; Huang J; Tang Y; Gan P; Zhong M BMC Cancer; 2013 Jun; 13():314. PubMed ID: 23806209 [TBL] [Abstract][Full Text] [Related]
7. The diagnostic accuracy of HE4 in lung cancer: a meta-analysis. Cheng D; Sun Y; He H Dis Markers; 2015; 2015():352670. PubMed ID: 25873748 [TBL] [Abstract][Full Text] [Related]
8. Clinical value of circulating tumor cells for the diagnosis and prognosis of hepatocellular carcinoma (HCC): A systematic review and meta-analysis. Cui K; Ou Y; Shen Y; Li S; Sun Z Medicine (Baltimore); 2020 Oct; 99(40):e22242. PubMed ID: 33019399 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of circulating microRNAs for nasopharyngeal cancer: a systematic review and meta-analysis. Wang Z; Chen W; Zhang Y; Xu L; Wang Q J Cancer Res Ther; 2014 Nov; 10 Suppl():C173-8. PubMed ID: 25450278 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic and prognostic value of blood samples for KRAS mutation identification in lung cancer: a meta-analysis. Shen H; Che K; Cong L; Dong W; Zhang T; Liu Q; Du J Oncotarget; 2017 May; 8(22):36812-36823. PubMed ID: 28415658 [TBL] [Abstract][Full Text] [Related]
11. Clinicopathological Significance and Diagnostic Value of DLEC1 Hypermethylation in Lung Cancer: A Meta-analysis. Li X; Mao W; Guo D; Xu H J Nippon Med Sch; 2019; 86(2):62-69. PubMed ID: 31130567 [TBL] [Abstract][Full Text] [Related]
12. Is it feasible to detect epidermal growth factor receptor mutations in circulating tumor cells in nonsmall cell lung cancer?: A meta-analysis. Liu Y; Xing Z; Zhan P; Liu H; Ye W; Lv T; Song Y Medicine (Baltimore); 2016 Nov; 95(47):e5115. PubMed ID: 27893656 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of SHOX2 DNA methylation in lung cancer: a meta-analysis. Zhao QT; Guo T; Wang HE; Zhang XP; Zhang H; Wang ZK; Yuan Z; Duan GC Onco Targets Ther; 2015; 8():3433-9. PubMed ID: 26640383 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of programmed cell death-ligand 1 expression on circulating tumor cells in lung cancer: A systematic review and meta-analysis. Cui M; Wan Z; Yang J; Liao D; Yang Y; Xiang Y Int J Biol Markers; 2023 Dec; 38(3-4):159-166. PubMed ID: 37545433 [TBL] [Abstract][Full Text] [Related]
15. Value of circulating tumor cell assisting low-dose computed tomography in screening pulmonary nodules based on existing liquid biopsy techniques: a systematic review with meta-analysis and trial sequential analysis. Wang Y; Duan Y; Guo D; Lv H; Li Q; Liu X; Qiao N; Meng H; Zhang X; Lan L; Liu X; Liu X Clin Transl Oncol; 2024 Dec; 26(12):3252-3263. PubMed ID: 38869739 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of various liquid biopsy methods for pancreatic cancer: A systematic review and meta-analysis. Zhu Y; Zhang H; Chen N; Hao J; Jin H; Ma X Medicine (Baltimore); 2020 Jan; 99(3):e18581. PubMed ID: 32011436 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of circulating microRNAs in thyroid carcinoma: A systematic review and meta-analysis. Xu SL; Tian YY; Zhou Y; Liu LQ Clin Endocrinol (Oxf); 2020 Oct; 93(4):489-498. PubMed ID: 32379941 [TBL] [Abstract][Full Text] [Related]
18. A panel of circulating miRNAs as diagnostic biomarkers for screening multiple myeloma: a systematic review and meta-analysis. Zhang L; Cao D; Tang L; Sun C; Hu Y Int J Lab Hematol; 2016 Dec; 38(6):589-599. PubMed ID: 27870469 [TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of microRNA-21 in the diagnosis of lung cancer: evidence from a meta-analysis involving 11 studies. Wu R; Jiang Y; Wu Q; Li Q; Cheng D; Xu L; Zhang C; Zhang M; Ye L Tumour Biol; 2014 Sep; 35(9):8829-36. PubMed ID: 24880588 [TBL] [Abstract][Full Text] [Related]
20. The diagnostic value of miRNA-141 in prostate cancer: A systematic review and PRISMA-compliant meta-analysis. Ye Y; Yuan XH; Wang JJ; Wang YC; Li SL Medicine (Baltimore); 2020 May; 99(22):e19993. PubMed ID: 32481368 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]